Related Experiment Video
Updated: Jun 12, 2026
04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Do we need to determine viral genotype in treating chronic hepatitis B?
1Discipline of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane, QLD, Australia. ecooksl@bigpond.com
Journal of Viral Hepatitis
|June 10, 2010
Summary
Hepatitis B virus (HBV) genotype impacts disease progression and treatment response. Genotyping is crucial for personalized therapy, guiding the use of pegylated interferon for better outcomes in chronic hepatitis B management.
Area of Science:
- Hepatology
- Virology
- Genetics
Background:
- Hepatitis B virus (HBV) genotype is known to affect disease progression and treatment efficacy.
- Interferon-based therapies show variable responses depending on HBV genotype and ethnicity.
Purpose of the Study:
- To evaluate the significance of HBV genotyping in managing chronic hepatitis B.
- To determine if HBV genotyping should be integrated into clinical management guidelines.
Main Methods:
- Review of existing studies on HBV genotypes and treatment outcomes.
- Analysis of recommendations from regional and national hepatitis organizations.
Main Results:
- HBV genotype influences treatment outcomes with interferons and pegylated interferons.
- Genotype A is associated with better outcomes than D in Caucasians; B better than C in Asians.
- Regional guidelines (AASLD, APASL, EASL) do not currently recommend routine genotyping.
Conclusions:
- National organizations and experts recommend HBV genotyping for personalized therapy.
- Genotyping helps identify patients likely to respond to pegylated interferon, avoiding nucleoside analogue resistance.
- HBV genotype determination should be part of chronic hepatitis B management.
More Related Videos
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...